The authors recommend a strategy for classifying similar nonstainless-steel surfaces into three groups based upon the analytical recovery that was observed in this study.
Jeffrey D. Hofer
Advertisement
Jeffrey D. Hofer is a senior statistician in Global Statistical Sciences at Eli Lilly and Company.
Articles by Jeffrey D. Hofer
This article discusses a straightforward approach that scientists may use to descide how many nonsuspect restest results are required to provide sufficient evidence to overcome an initial suspect result.
Advertisement
Latest Updated Articles
A Risk-Management Approach to Cleaning-Assay ValidationPublished: June 2nd 2010 | Updated:
- Routine Sample Size for a Retest Procedure
Published: November 2nd 2003 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
Challenges for the Global Manufacturing of Vaccines
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
